miRNA |
Drug Name |
CID |
NSC |
FDA |
Effect/Pattern |
Detection Method |
Level |
Phenotype |
Condition |
hsa-mir-939 |
Dabrafenib |
44462760 |
NSC764134 |
approved |
resistant |
|
|
|
cell line (A375) |
hsa-mir-939 |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (BxPC3) |
hsa-mir-939 |
Ceritinib |
57379345 |
NSC776422 |
approved |
resistant |
|
|
|
cell line (H3122) |
hsa-miR-939-5p |
-d-xylose |
24203222 |
NSC727221 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
(-)7,8-dihydrocalanolide a |
383107 |
NSC682400 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
(10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) 3-methylidene-2-oxo-6-oxabicyclo[3.1.0]hexane-1-carboxylate |
495432 |
NSC654893 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
(2E)-2-[2-(4-bromophenyl)-2-oxoethylidene]-5-(2,4-dimethylphenyl)furan-3-one |
5468713 |
NSC674919 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
(nz)-n-[1-[4-[(4-imidazol-1-ylquinolin-2-yl)amino]phenyl]ethylidene]hydroxylamine |
24204871 |
NSC733301 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
.beta.-phenylethyl 2,4,5-trihydroxycinnamate |
5933247 |
NSC666592 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
[(3bR,9aS,11aS)-2-(2-hydroxy-5-oxo-2H-furan-3-yl)-3b,6,6,9a-tetramethyl-2,3,3a,4,5,5a,7,8,9,9b,10,11-dodecahydronaphtho[2,1-e][1]benzofuran-11a-yl]methyl acetate |
378635 |
NSC661428 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
[(3S,10R,13S,16E)-16-[[3-methoxy-4-(2-piperidin-1-ylethoxy)phenyl]methylidene]-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
24203176 |
NSC727082 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
[[5-[(4-bromophenyl)diazenyl]-2-hydroxyphenyl]-[2-[3-(2-chloroanilino)-3-oxopropanoyl]hydrazinyl]methyl]phosphonous acid |
377940 |
NSC659608 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
[2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-ylidene]sulfanium;(2-hydroxy-5-nitrophenyl)mercury |
135403618 |
NSC321239 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
[bis(aminomethyl)diethylsilane]dichloroplatinum (ii) |
|
NSC645351 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
[dibutyl-(2,6-difluorobenzoyl)oxy-stannyl] 2,6-difluorobenzoate |
16683188 |
NSC643841 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
1-[2-(2,4-dinitrophenyl)sulfonyl-1-methylene-allyl]sulfonyl-2,4-dinitro-benzene |
361138 |
NSC623970 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
1h-benzo[a]carbazole-1,4(11h)-dione, 11-methyl- |
261066 |
NSC92937 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
1h-imidazole-4-carboxamide, 5-(3-methyl-1-tetrazenyl)- |
135493930 |
NSC684047 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
2-(4-methylphenyl)-5-(2-naphthyl)-1,3,4-oxadiazole |
260000 |
NSC90810 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
2-(5-chloro-2-methylanilino)-6-(trifluoromethyl)pyridine-3-carboxamide |
24204601 |
NSC732287 |
|
resistant |
|
|
|
|
hsa-miR-939-5p |
2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline |
24203444 |
NSC728037 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
2-[[(2-aminobenzoyl)oxy-dibutyl-stannyl]amino]benzoic acid |
16684416 |
NSC628572 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
2-[3-chloro-3-(4-chloro-phenyl)-allylidene]-malononitrile |
5473313 |
NSC725048 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
2-acetyl-1,2-dihydroellipticine |
376328 |
NSC657149 |
|
resistant |
|
|
|
|
hsa-miR-939-5p |
2-methyl-1-(2,3,4,5,6-pentafluorobenzoyl)-1h-benzimidazole |
383504 |
NSC671889 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
2-nitro-1-phenylpropan-1-ol |
226118 |
NSC16258 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-(2-naphthalenylthio)- |
314728 |
NSC234214 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
3-iodoacetamido-benzoic acid ethyl ester |
398530 |
NSC708445 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
3,4,5-trimethoxy-n-(4h-pyrrolo[2,1-c][1,4]benzoxazin-1-ylmethyl)aniline |
403776 |
NSC719249 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
3,4,8-trimethyl-7-((2-methyl-4-methylene-5-oxotetrahydro-2-furanyl)methoxy)-2h-chromen-2-one |
381508 |
NSC668264 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
4-(6-thioguanine)-7-nitro-2,1,3-benzoxadiazole |
3246652 |
NSC348401 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
4-[(2Z)-2-[1-amino-3-(methylamino)-1,3-bis(sulfanylidene)propan-2-ylidene]hydrazinyl]-1H-imidazole-5-carboxamide |
5466293 |
NSC684046 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
4-[(6-sulfanylidene-3,7-dihydropurin-8-yl)diazenyl]benzenesulfonamide |
3246283 |
NSC75140 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
4-[(z)-indolo[1,2-b]indazol-11-ylidenemethyl]-n,n-dimethylaniline |
5472473 |
NSC719163 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
5,7-bis(dibromomethyl)-3-nitropyrazolo[1,5-a]pyrimidin-2-amine |
384486 |
NSC674312 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
7-benzyl-3-[(e)-3-oxo-3-phenylprop-1-enyl]-16-thia-2,4,5,7-tetrazatetracyclo[7.7.0.02,6.010,15]hexadeca-1(9),3,5,10(15)-tetraen-8-one |
45028585 |
NSC743396 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
7-chloro-10,11-dimethoxy-2,8-diazatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaene-3,4-dione |
397794 |
NSC706232 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
8-(6-fluorohexyl)-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride |
380336 |
NSC665863 |
|
resistant |
|
|
|
|
hsa-miR-939-5p |
8(5h)-quinolinone, 7-chloro-5-[[4-(diethylamino)-2-methylphenyl]imino]- |
363174 |
NSC627778 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Aplidazole c . tfa |
362402 |
NSC626167 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Artelasticin |
5471311 |
NSC710342 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Benzene, 1,1'-[(1,3-butadiene-1,4-diyl)sulfonyl]bis |
5468033 |
NSC662781 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2h,6h)-tetraimine |
359178 |
NSC619860 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Carbon monoxide;iridium;1-phenyldiazenylnaphthalen-2-olate |
6711627 |
NSC632877 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Cps49 |
9905583 |
NSC726796 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Dacarbazine |
5351166 |
NSC45388 |
approved |
sensitive |
|
|
|
|
hsa-miR-939-5p |
Eh00008 |
354026 |
NSC603974 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Gnmlngdfmleynr-uhfffaoysa-n |
402862 |
NSC717147 |
|
resistant |
|
|
|
|
hsa-miR-939-5p |
Herveline o |
5459269 |
NSC676002 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Incarnal |
131851 |
NSC648322 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Leinamycin |
5459203 |
NSC645777 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
M-232 |
403374 |
NSC718170 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Melampodinin |
5359028 |
NSC294600 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Methyl (1S,4S)-6,11-dioxo-4-[3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-1,4-dihydropyridazino[1,2-b]phthalazine-1-carboxylate |
385569 |
NSC676858 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Mp 317 |
16683647 |
NSC30916 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
N-(((2-methoxy-5-(trifluoromethyl)anilino)carbonyl)oxy)butanimidoyl chloride |
9556202 |
NSC672059 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
N-(2-aminophenyl)-4-[3-(3-methyl-2,5-dioxoimidazolidin-1-yl)prop-1-en-2-yl]benzamide |
11682081 |
NSC736099 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Niveusin a |
5477575 |
NSC331121 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
NSC621339 |
|
NSC621339 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Pc 287 |
239486 |
NSC44580 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Phenethyl 3-(3,4-dihydroxyphenyl)propanoate |
380847 |
NSC666586 |
|
sensitive |
|
|
|
|
hsa-miR-939-5p |
Prumycin |
5458561 |
NSC278619 |
|
resistant |
|
|
|
|
hsa-miR-939-5p |
Stk673848 |
403091 |
NSC717563 |
|
resistant |
|
|
|
|
hsa-miR-939-5p |
Tamoxifen |
2733525 |
NSC180973 |
approved |
sensitive |
|
High |
Breast Cancer |
cell line (MCF-7, LY2) |
hsa-miR-939-5p |
Oxaliplatin |
6857599 |
NSC266046 |
approved |
resistant |
|
High |
Colorectal Cancer |
cell line (HCT-116) |
hsa-miR-939-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
sensitive |
|
High |
Pancreatic Cancer |
cell line (PANC-1) |
hsa-miR-939-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
sensitive |
|
High |
Pancreatic Cancer |
cell line (PANC-1) |
hsa-miR-939-5p |
Bortezomib |
387447 |
NSC681239 |
approved |
resistant |
|
High |
Multiple Myeloma |
cell line |
hsa-miR-939-5p |
Imatinib |
5291 |
NSC743414 |
approved |
sensitive |
|
High |
Gastrointestinal Stromal Tumor |
tissue |
hsa-miR-939-5p |
Platinum |
23939 |
|
|
sensitive |
|
High |
Ovarian Cancer |
tissue |
hsa-miR-939-5p |
Capecitabine + Oxaliplatin |
|
|
|
resistant |
|
High |
Colon Adenocarcinoma |
tissue |
hsa-miR-939-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
sensitive |
|
Low |
Gastric Cancer |
cell line (AGS, BGC-823, HGC-27, MGC-803, MNK-45, SGC-7901) |
hsa-miR-939-5p |
Oxaliplatin |
6857599 |
NSC266046 |
approved |
resistant |
|
High |
Colorectal Cancer |
cell line (HCT-116, HT-29) |
hsa-miR-939-5p |
Tamoxifen |
2733525 |
NSC180973 |
approved |
resistant |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-939-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
sensitive |
|
High |
Endometrial Serous Carcinoma |
cell line (USPC1) |
hsa-miR-939-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Hypopharyngeal Cancer |
cell line (FaDu) |
hsa-miR-939-5p |
Temozolomide |
5394 |
NSC362856 |
approved |
resistant |
|
|
|
cell line (U251) |
hsa-miR-939-5p |
Gefitinib |
123631 |
NSC715055 |
approved |
resistant |
|
|
|
cell line (HCC827) |
hsa-miR-939-5p |
Osimertinib |
71496458 |
NSC779217 |
approved |
resistant |
|
|
|
cell line (HCC827) |
hsa-miR-939-5p |
Gefitinib |
123631 |
NSC715055 |
approved |
sensitive |
|
|
|
cell line (HCC827) |
hsa-miR-939-5p |
Osimertinib |
71496458 |
NSC779217 |
approved |
sensitive |
|
|
|
cell line (H1975) |
hsa-miR-939-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (MGC-803) |
hsa-miR-939-5p |
4-Hydroxytamoxifen+Tamoxifen |
|
|
|
resistant |
|
|
|
cell line (LY2) |
hsa-miR-939-5p |
Ethanol+Tamoxifen |
|
|
|
resistant |
|
|
|
cell line (LY2) |
hsa-miR-939-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (RPMI2650) |
hsa-miR-939-5p |
Sunitinib |
5329102 |
NSC750690 |
approved |
resistant |
|
|
|
tissue (CardB) |
hsa-miR-939-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (A549) |
hsa-miR-939-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
sensitive |
|
|
|
cell line (PANC-1) (1500 ng/ml) |
hsa-miR-939-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (OVCAR3) |
hsa-miR-939-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (H23) |
hsa-miR-939-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (A549) |
hsa-miR-939-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (OVSAHO) |
|